[Standardization and issues of rheumatoid factor measurement]

Area of Science:

• Clinical chemistry
• Immunology
• Laboratory medicine

Context:

• Rheumatoid factor (RF) is a crucial biomarker in diagnosing and monitoring autoimmune diseases, particularly rheumatoid arthritis.
• Standardization of RF measurement is essential for accurate clinical interpretation and patient management.
• Previous studies have indicated potential variability in RF assay results across different laboratories.

Purpose:

• To assess the current landscape of rheumatoid factor (RF) measurement practices in Japan.
• To identify the extent of inter-laboratory variability in RF quantification.
• To determine the factors contributing to discrepancies in RF testing.

Summary:

• A survey of Japanese educational institutes revealed significant inter-laboratory differences in rheumatoid factor (RF) measurements, particularly when using manufacturer-specific reference materials.
• Quantitative methods, predominantly latex immunoassay (turbidimetric or nepherometric), were widely adopted, yet a broad range in upper reference interval limits (5–40 IU/ml) was observed.
• The study highlights a critical need for standardized RF reference materials and collaborative efforts between scientific societies and manufacturers to enhance measurement consistency.

Impact:

• The findings underscore the urgent need for standardized rheumatoid factor (RF) reference materials to reduce diagnostic variability.
• Establishing consistent RF measurement protocols will improve the reliability of diagnostic and prognostic assessments for patients with autoimmune conditions.
• This research calls for a unified approach involving the Japan College of Rheumatology, the Japanese Society of Laboratory Medicine, and reagent manufacturers to elevate the quality of RF testing in Japan.